Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 1066 AL 1080

[Psychosis and movement disorders in an adolescent with 22q11.2 deletion syndrome]

Zinkstok JR, Velders F, Rieken R, Houben M, Fiksinski A, van Amelsvoort TAMJ, Boot E.

Tijdschr Psychiatr. 2020;62(3):229-233.

Quantitative Structure-Activity Relationship (QSAR) Studies for the Inhibition of MAOs

Ramesh M, Muthuraman A.

Comb Chem High Throughput Screen. 2020;23(9):887-897. doi: 10.2174/1386207323666200324173231.

Advanced diffusion magnetic resonance imaging in patients with Alzheimer's and Parkinson's diseases

Kamagata K, Andica C, Hatano T, Ogawa T, Takeshige-Amano H, Ogaki K, Akashi T, Hagiwara A, Fujita S, Aoki S.

Neural Regen Res. 2020 Sep;15(9):1590-1600. doi: 10.4103/1673-5374.276326.

Exosomes from Human Periapical Cyst-MSCs: Theranostic Application in Parkinson's Disease

Tatullo M, Marrelli B, Zullo MJ, Codispoti B, Paduano F, Benincasa C, Fortunato F, Scacco S, Zavan B, Cocco T.

Int J Med Sci. 2020 Feb 24;17(5):657-663. doi: 10.7150/ijms.41515. eCollection 2020.

The Effect of Estrogen Replacement Therapy on Alzheimer's Disease and Parkinson's Disease in Postmenopausal Women: A Meta-Analysis

Song YJ, Li SR, Li XW, Chen X, Wei ZX, Liu QS, Cheng Y.

Front Neurosci. 2020 Mar 10;14:157. doi: 10.3389/fnins.2020.00157. eCollection 2020.

Leucine Rich Repeat Kinase 2 and Innate Immunity

Ahmadi Rastegar D, Dzamko N.

Front Neurosci. 2020 Mar 10;14:193. doi: 10.3389/fnins.2020.00193. eCollection 2020.

Proteostasis of α-Synuclein and Its Role in the Pathogenesis of Parkinson's Disease

Han D, Zheng W, Wang X, Chen Z.

Front Cell Neurosci. 2020 Mar 10;14:45. doi: 10.3389/fncel.2020.00045. eCollection 2020.

From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases

Cassano T, Villani R, Pace L, Carbone A, Bukke VN, Orkisz S, Avolio C, Serviddio G.

Front Pharmacol. 2020 Mar 6;11:124. doi: 10.3389/fphar.2020.00124. eCollection 2020.

Quadripulse stimulation (QPS)

Matsumoto H, Ugawa Y.

Exp Brain Res. 2020 Aug;238(7-8):1619-1625. doi: 10.1007/s00221-020-05788-w. Epub 2020 Mar 24.

Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management

O'Brien J, Taylor JP, Ballard C, Barker RA, Bradley C, Burns A, Collerton D, Dave S, Dudley R, Francis P, Gibbons A, Harris K, Lawrence V, Leroi I, McKeith I, Michaelides M, Naik C, O'Callaghan C, Olsen K, Onofrj M, Pinto R, Russell G, Swann P, Thomas A, Urwyler P, Weil RS, Ffytche D.

J Neurol Neurosurg Psychiatry. 2020 May;91(5):512-519. doi: 10.1136/jnnp-2019-322702. Epub 2020 Mar 25.

Therapeutic Potential of Diosgenin and Its Major Derivatives against Neurological Diseases: Recent Advances

Cai B, Zhang Y, Wang Z, Xu D, Jia Y, Guan Y, Liao A, Liu G, Chun C, Li J.

Oxid Med Cell Longev. 2020 Mar 6;2020:3153082. doi: 10.1155/2020/3153082. eCollection 2020.

What and How Can Physical Activity Prevention Function on Parkinson's Disease?

Fan B, Jabeen R, Bo B, Guo C, Han M, Zhang H, Cen J, Ji X, Wei J.

Oxid Med Cell Longev. 2020 Feb 13;2020:4293071. doi: 10.1155/2020/4293071. eCollection 2020.

Effect of Antidepressants on Psychotic Symptoms in Parkinson Disease: A Review of Case Reports and Case Series

Sid-Otmane L, Huot P, Panisset M.

Clin Neuropharmacol. 2020 May/Jun;43(3):61-65. doi: 10.1097/WNF.0000000000000384.

Ablation for Wolff-Parkinson-White syndrome: a life‑saving procedure

Giaccardi M.

Kardiol Pol. 2020 Mar 25;78(3):177-178. doi: 10.33963/KP.15248. Epub 2020 Mar 25.

Progressive Supranuclear Palsy-Parkinsonism Predominant (PSP-P)-A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD)

Alster P, Madetko N, Koziorowski D, Friedman A.

Front Neurol. 2020 Mar 10;11:180. doi: 10.3389/fneur.2020.00180. eCollection 2020.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias